Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: AF-predict AI-ECG alert system guided management.
- Who it may be relevant to
- Registry conditions: Atrial Fibrillation (AF), Premature Atrial Complexes, Atrial Arrhythmias, Artificial Intelligence (AI). Basic parameters: 40 Days — 85 Days · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Taiwan
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development: a Randomized Control Trial
Overview
Our study aimed to use an AF-predict AI-ECG alert system to help physicians identify patients who need to wear a continuous cardiac rhythm monitor for new diagnoses of atrial fibrillation (AF), atrial flutter (AFL), or atrial arrhythmia with high AF risk, including premature atrial complexes (PAC) ≥ 500/24hr, burst PACs \> 20 beats, non-sustained AF/AFL.
Interventions
- Other AF-predict AI-ECG alert system guided management
AF-predict AI-ECG alert system
Primary outcome measures
- Latent atrial fibrillation [Time frame: Within 90 days after enrollment.]
Secondary outcome measures (3)
- Antiarrhythmic treatment [Time frame: Within 180 days after enrollment.]
- 90-days New diagnoses of atrial fibrillation/atrial flutter [Time frame: Within 90 days after enrollment.]
- Atrial arrhythmia with high AF risk [Time frame: Within 90 days after enrollment.]
Eligibility criteria
Inclusion criteria
- Patients in the inpatient department or the outpatient department
- Patients need to have at least one electrocardiogram within one year
Exclusion criteria
- Diagnosis of atrial fibrillation/atrial flutter
- History of atrial fibrillation/atrial flutter catheter ablation
- Patients with cardiac implantable electronic devices
- Any documented electrocardiogram showed atrial fibrillation/atrial flutter and pacing rhythm
- History of received rhythm control medications for atrial arrhythmia, including Class I and Class III antiarrhythmic drugs
- Any reasons indicate for anti-coagulant agents, including vitamin K antagonist and non-vitamin K antagonist oral anticoagulant
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Diagnostic
Study locations
Taiwan · 1 center
- Tri-Service General Hospital — Taipei
Identifiers
NCT: NCT06847932 · A202205179